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Background: Measurement of genome-wide DNA methylation (DNAm) has become an important avenue for
investigating potential physiologically-relevant epigenetic changes. Illumina Infinium (Illumina, San Diego, CA, USA)
is a commercially available microarray suite used to measure DNAm at many sites throughout the genome.
However, it has been suggested that a subset of array probes may give misleading results due to issues related to
probe design. To facilitate biologically significant data interpretation, we set out to enhance probe annotation of
the newest Infinium array, the HumanMethylation450 BeadChip (450 k), with >485,000 probes covering 99% of
Reference Sequence (RefSeq) genes (National Center for Biotechnology Information (NCBI), Bethesda, MD, USA).
Annotation that was added or expanded on includes: 1) documented SNPs in the probe target, 2) probe binding
specificity, 3) CpG classification of target sites and 4) gene feature classification of target sites.
Results: Probes with documented SNPs at the target CpG (4.3% of probes) were associated with increased within-
tissue variation in DNAm. An example of a probe with a SNP at the target CpG demonstrated how sample
genotype can confound the measurement of DNAm. Additionally, 8.6% of probes mapped to multiple locations in
silico. Measurements from these non-specific probes likely represent a combination of DNAm from multiple
genomic sites. The expanded biological annotation demonstrated that based on DNAm, grouping probes by an
alternative high-density and intermediate-density CpG island classification provided a distinctive pattern of DNAm.
Finally, variable enrichment for differentially methylated probes was noted across CpG classes and gene feature
groups, dependant on the tissues that were compared.
Conclusion: DNAm arrays offer a high-throughput approach for which careful consideration of probe content
should be utilized to better understand the biological processes affected. Probes containing SNPs and non-specific
probes may affect the assessment of DNAm using the 450 k array. Additionally, probe classification by CpG
enrichment classes and to a lesser extent gene feature groups resulted in distinct patterns of DNAm. Thus, we
recommend that compromised probes be removed from analyses and that the genomic context of DNAm is
considered in studies deciphering the biological meaning of Illumina 450 k array data.
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Measuring epigenetic marks has become an attractive
approach for connecting phenotype, genetics and envir-
onment in many fields of medicine [1-3]. DNA methyla-
tion (DNAm), the addition of a methyl group primarily
to cytosines in the context of CpG dinucleotides, is one
such highly studied epigenetic mark. Epigenome-wide
association studies (EWAS) of DNAm have been pro-
posed as a complement to genome-wide association
studies (GWAS) for elucidating loci correlated with
complex disease [4]. Although these large-scale associ-
ation studies provide a great amount of information,
there are currently limits to our ability to interpret this
data [5] given the variability of DNAm across individ-
uals, ethnicities, sex, age, tissue type and environment
[6,7]. To improve the analysis potential of a popular tool
for large-scale measurement of DNAm, the Infinium
HumanMethylation450 BeadChip (450 k) (Illumina, San
Diego, CA, USA), we have annotated technically unreli-
able probes and enhanced the biological annotation of
this DNAm microarray.
The 450 k array combines two technically distinct assays
in one platform: the Infinium I assay (type I probes) and
Infinium II assay (type II probes) (see methods section for
details). The design and specifications of the 450 k array
have been discussed in other publications [8-10], and
extensive probe annotation is available from Illumina to
aid users in data interpretation. This annotation includes,
for example, probe location within genes (annotated by
University of California, Santa Cruz (UCSC) Genome
Browser (http://genome.ucsc.edu; UCSC Genome Bio-
informatics, Santa Cruz, CA, USA), CpG islands and
shores, and regulatory features. However, recently tech-
nical limitations of the Infinium platform have been de-
scribed [11,12]. In 2011, an evaluation of an earlier
version of the array, the Infinium HumanMethylation27k
BeadChip (27 k) that used exclusively the Infinium I assay,
identified two groups of probes as possibly compromised
by their design [10]. The first group, accounting for about
6 to 10% of the 27 k array, was non-specific probes, that
is, probes that hybridized to multiple genomic locations in
silico. The level of DNAm at non-specific probes likely re-
flects a combination of DNAm at the various locations to
which these probes hybridize. The second group of unreli-
able probes was those with a polymorphic target (0.24% of
27 k probes). Since the Infinium DNAm platform uses
quantitative genotyping of C/T SNPs introduced following
bisulfite conversion to determine the level of DNAm,
probes with polymorphisms at the target C or G have
the potential of assessing a difference in genotype rather
than a true difference in DNAm. A corresponding in-
crease in the number of both non-specific probes and
polymorphic probes is expected given the similar tech-
nology of the 450 k array [12].CpG dinucleotides are not randomly distributed
throughout the genome, most have spontaneously de-
aminated with the exception of some CpG-enriched re-
gions known as ‘CpG islands’ [13]. About 70% of gene
promoters are associated with CpG islands [14] and
traditionally gene transcription has been thought to be
repressed by the presence of promoter CpG island
DNAm [15,16]. There are different approaches for clas-
sifying CpG enrichment, for example, UCSC defines
CpG islands based on CG content >50%, Observed/
Expected (Obs/Exp) CpG ratio >0.6 and length >200
bps [17]. An alternative classification of CpG islands
providing more enrichment discrimination is high-
density CpG islands (HCs, CG content >55%, Obs/Exp
CpG ratio >0.75 and length >500 bps), intermediate-
density CpG islands (ICs, CG content >50%, Obs/Exp
CpG ratio >0.48 and length >200 bps) and non-islands
(LCs or low-density CpG regions, non-HC/IC regions)
[16,18]. However, the most biologically meaningful def-
inition of CpG enrichment remains to be determined.
In the past, many DNAm studies focused on pro-
moters and CpG islands however, recently attention has
also turned towards the study of DNAm patterns in the
regions surrounding islands, known as shores. CpG is-
land shores have been observed to be variably methyl-
ated between unrelated individuals, in cancer and in iPS
cell lines [19-21]. The level of DNAm in shores may in
fact be more highly correlated with gene expression than
that of CpG islands [22]. Furthermore, tissue-specific
gene expression has been associated with tissue differ-
ences in DNAm at shores [19], perhaps as a conse-
quence of transcription machinery binding to nearby
promoter CpG islands. Others have shown that DNAm
outside of CpG islands and shores may also be associ-
ated with gene expression. For example, one study iden-
tified lower levels of gene body DNAm associated with
the lowest and highest levels of gene expression, whereas
higher levels of gene body DNAm were associated with
intermediate levels of gene expression [23].
While the 450 k array offers the opportunity to exam-
ine DNAm at individual CpGs across CpG island and
non-island regions, the inclusion of this diverse range of
sites requires a more complex and detailed annotation
of the array. To enhance the utility of the 450 k array,
we increased probe annotation in four areas: 1) docu-
mented SNPs in the target CpG, 2) probe binding speci-
ficity, 3) CpG classification of target sites and 4) gene
feature classification of target sites. We tested the ex-
panded annotation in a set of control samples of interest
to our investigations: adult blood (n = 4), child buccal
(n = 4) and placental chorionic villi (n = 4), and followed
up some analyses in a larger, publically available blood
dataset (n = 261). In particular, we evaluated DNAm pat-
terns relative to functional aspects of probe location,
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probes. Based on our analyses, we recommend that users
analyze 450 k data with the following factors in mind: 1)
DNAm measured at probes with SNPs in the target site
may be compromised by sample genotype, 2) DNAm
measured at non-specific probes may not only represent
the intended site of hybridization and 3) DNAm varies
across CpG enrichment classes as well as gene features.
Results and discussion
Polymorphic CpGs may affect the assessment of DNAm
Infinium assays are based on quantifying bisulfite-
introduced C/T SNPs, thus the actual DNA sequence at
the target CpG is at risk of compromising the assess-
ment of DNAm. The end of each 450 k probe targets a
CpG of interest and although the alignment of type I
and type II probes with CpGs differs by one base pair
(Additional file 1), end nucleotide match is essential for
extension of both probe types. A SNP leading to a se-
quence change at a target CpG might result in a false
DNAm signal due to hybridization of the wrong probe
(possible for type I probes) or no/minimal extension at
the target site (possible for both probe types). Illumina
included annotation of SNPs located within 10 bps of the
target CpG (SNP <10 bp, n = 36,535 probes) and those
located within the remainder of the probe (SNP >10 bp,
n = 59,892 probes). We have added annotation of probes
that query CpGs with documented polymorphisms specif-
ically at the C and/or G position (target CpG SNPs).
Using the database of single nucleotide polymorphisms
(dbSNP, National Center for Biotechnology Information
(NCBI), Bethesda, MD, USA), one or more SNPs were
annotated at 4.3% (n = 20,869) of target CpGs (Figure 1A).
Most of these probes had only one target CpG SNP
(n = 20,270), however, 599 had two or more (Additional
file 2); 32.5% of probes with a target CpG SNP were not
documented as variable by dbSNP, while 43.2% had a het-
erozygosity greater than 0.1 (Figure 1A). Being more fre-
quent in the population, this second group of SNPs is
more likely to affect the assessment of DNAm. The major-
ity (67.3%) of the rs numbers for probes with target CpG
SNPs corresponded to those annotated by Illumina as a
SNP <10 bp. Differences between the annotations may be
a result of our inclusion of SNPs in the C or G of the tar-
get CpG (whereas Illumina only annotated SNPs in the
probe sequence, see Additional file 1), updates to the
dbSNP database and the possibility that Illumina used a
minimum heterozygosity as SNP inclusion criteria.
Theoretically, a bi- or tri-modal distribution of DNAm
would be produced by a probe affected by sample geno-
types at a target CpG SNP and this pattern would result
in a high within-tissue SD in ß value (450 k array meas-
ure of DNAm ranging from 0 to 1). Thus, we examined
the distribution of within-tissue SD in ß (n = 4/tissue) atprobes annotated with a target CpG SNP, SNP <10 bp
(excluding those probes also annotated with a target
CpG SNP) and SNP >10 bp (Figure 1B, results for
blood). The distribution of SD in ß for probes annotated
with a target CpG SNP was most different (p= 1.78 ×
19-15) from that of all probes based on a Kolmogorov-
Smirnov (KS) test for difference in distribution. This
trend was illustrated by a shift in the density curve for
SD in ß of probes with target CpG SNPs in comparison
to the curve for SD in ß of all probes (Figure 1B). To en-
sure that this finding was not an artifact of our small
sample size, we performed the same analysis using a
larger, publically available dataset, Gene Expression
Omnibus (GEO) [GSE:40279], that had investigated
age-associated DNAm changes in the blood of 656 indi-
viduals (aged 19 to 101 years) [24]. We extracted the
younger half of samples (n = 261, aged 19 to 61 years) for
our analysis since this roughly covered the age of the
blood samples in our study. In this larger dataset (referred
to as the ‘aging dataset’), the distribution of SD in ß for
probes annotated with a target CpG SNP also exhibited
the largest difference in distribution from that of all
probes (p = 1.22 × 10-14) based on a KS test (Figure 1C).
We next hypothesized that highly variable probes (de-
fined as within-tissue SD in ß ≥0.25), were likely
compromised by the presence of a target CpG SNP.
There were 780 such probes in blood, 819 in buccal, 666
in chorionic villus samples and 480 in the aging dataset
that met this criterion (Table 1). We did not expect the
number of probes affected by SNPs to be the same
across tissues since all samples were from different indi-
viduals and thus of different genotypes. Comparing these
variably methylated probes to the SNP annotation,
85.0%, 81.6%, 72.7% and 92.5% were annotated with a
target CpG SNP in blood, buccal, chorionic villus sam-
ples and the aging dataset, respectively (Table 1). Of the
highly variable probes, only four in blood, two in buccal
and two in chorionic villi overlapped with the sex-
specific autosomal probes described in the next section,
thus we do not believe that these large SDs were driven
by sex differences in the data. No probes in the aging
dataset met this criterion.
To confirm that a target CpG SNP could affect DNAm,
samples were genotyped at a probe (cg06961873) that had
an annotated target CpG SNP and SD in ß ≥0.25 in all
three tissues. As predicted, homozygous C samples were
assessed as hypermethylated, heterozygotes were assessed
as approximately 50% methylated and homozygous T sam-
ples as hypomethylated (Figure 1D). Although we were
not able to genotype samples, a histogram of DNAm at
this same CpG site across the 261 aging dataset samples
showed the same trimodal pattern of DNAm (Additional
file 3). Other examples of highly variable probes in the
aging dataset also illustrate this pattern (Additional file 3).
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Figure 1 Probes targeting polymorphic CpGs may affect the assessment of DNAm. (A) A documented SNP was identified at the target C or
G position of 4.3% of 450 k probes (target CpG SNP). Of these SNPs, 43.2% had a heterozygosity of >0.1 and due to their frequency in the
population are more likely to affect measurement of DNAm. (B) Using blood samples (n = 4) as example, the SD in ß value between individuals
was calculated for all probes. Probes with small SD in ß (<0.10) were removed from the analysis. The distribution of SD in ß value was plotted for
all probes, and for the subsets of probes annotated with a target CpG SNP, a SNP within 10 bps of the target but without a target CpG SNP (SNP
<10 bp) and a SNP within the remainder of the probe (SNP >10 bp). Numbers in brackets indicate Kolmogorov-Smirnov (KS) statistics in
comparison to the distribution of all probes. (C) Using a selection of 261 adult blood samples extracted from the aging dataset [GSE:40279], the
distribution of SD in ß value was plotted for the subsets of probes as described in (B). Numbers in brackets indicate KS statistics in comparison to
the distribution of all probes. (D) DNAm at probe cg06961873 across 12 individuals exemplified the trichotomous pattern of DNAm hypothesized
at a target CpG SNP. The three distinct levels of DNAm corresponded to sample genotype at SNP rs61775206, located at the target CpG: TT
genotypes were assessed as hypomethylated, TC genotypes as approximately 50% methylated and CC genotypes as close to fully methylated.
450 k, Infinium HumanMethylation450 BeadChip; DNAm, DNA methylation.
Price et al. Epigenetics & Chromatin 2013, 6:4 Page 4 of 15
http://www.epigeneticsandchromatin.com/content/6/1/4Given the demonstrated potential to bias the call of
DNAm, we suggest that probes with a target CpG SNP
should be disregarded in most analyses of the 450 k
array. At minimum, 450 k users should carefully check
candidate probes against the target CpG SNP annotation
in addition to a current SNP database, as more polymor-
phisms are likely to be identified and validated in com-
ing years. Although we have used a straightforward
example to illustrate how a target CpG SNP may con-
found the assessment of DNAm, effects may also be ob-
served at SNPs within the remainder of the probe, that
is, outside of the target CpG. For example, polymor-
phisms throughout the interval of hybridization have
been shown to affect the binding of probes used in
Illumina mRNA expression arrays [25], which have thesame probe lengths as the 450 k array. Similar effects
have also been observed in Affymetrix mRNA expression
arrays (Affymetrix, Santa Clara, CA, USA), although
these use shorter probes that might be more sensitive to
sequence mismatches [26]. Additionally, several studies
have recognized the heritability of DNAm through the
genetic-epigenetic interaction of methylation-associated
SNPs (mSNPs) [27,28], suggesting that some SNP-
associated differences in DNAm may be true differences
and not due to technical artifacts.
8 to 9% of probes mapped to more than one location in
silico
An additional confounding feature of the Infinium arrays
is that some probes potentially map to multiple locations
Table 1 The majority of highly variable probes were annotated with SNPs
Tissue
Highly variable probesa Blood Buccal Chorionic villi Aging dataset
Total 780 819 666 480
Annotated with target CpG SNP 663 (85.0) 668 (81.6) 484 (72.7) 444 (92.5)
aDefined as within-tissue SD in ß ≥0.25. Number in brackets is percentage (%) of total/tissue.
Price et al. Epigenetics & Chromatin 2013, 6:4 Page 5 of 15
http://www.epigeneticsandchromatin.com/content/6/1/4in the genome [10]. Signals from these non-specific
probes likely represent a combination of DNAm at more
than one location. Using alignment to four different in
silico bisulfite-treated genomes [10], we identified 11.2%
(n = 15,125) of type I probes and 7.7% (n = 26,812) of
type II probes on the 450 k array as non-specific (total
of 8.6% of 450 k probes). While the number of cross-
hybridization loci per probe ranged from 2 to 1615, the
majority of non-specific probes cross-hybridized to be-
tween two and five locations (52.4% of type I non-
specific probes and 65.2% of type II non-specific probes).
Within non-specific probes, 600 were intended to target
sex chromosomes but also mapped to autosomal
chromosomes, while 11,412 were intended to target
autosomal chromosomes but also mapped to sex chro-
mosomes (Table 2). Other publications have described
how this second group of probes may be problematic in
studies assessing sex differences in DNAm on autosomes
or in studies where male and female subjects are ana-
lyzed together [10,29]. Thus we included in our annota-
tion whether each probe cross-hybridized to sex or
autosomal chromosomes.
In the aging dataset, after excluding sex chromosome
probes, but not our annotated non-specific probes, we
used a false discovery rate (FDR) and minimum differ-
ence in DNAm (Δß) between sexes to identify autosomal
probes that were differentially methylated between males
(n = 133) and females (n = 128). An FDR of <1% and
minimum Δß of 10% identified 75 sex-specific auto-
somal probes of which 40% were annotated to cross-
hybridize to the sex chromosomes (Additional file 4).
Although some true sex differences in DNAm likely
exist on the autosomes, this result indicates that many
of the large autosomal sex differences in DNAm may beTable 2 Location of in silico cross-hybridization of non-specifi
Inte
Total on array 473,
Non-specific probes Cross-hybridize only to auto chrs 29,17
Cross-hybridize only to sex chrs 540
Cross-hybridize to auto and sex chrs 10,87
Total: cross-hybridize to sex chrs 11,41
Total: cross-hybridize to auto chrs 40,05
Total 40,59
Auto, autosomal; chrs, chromosomes.an artifact of probe design and likely actually represent
sex-chromosome differences in DNAm. Depending on the
research question, some investigators may choose to ex-
clude all or a subset of non-specific probes prior to data
analysis, while others may include them and follow-up
candidate probe specificity before establishing conclusions.
Homologous gene families, duplicated genes or repeti-
tive elements have been proposed as potential causes of
in silico cross-hybridization of Infinium probes [10].
Thus, for all 450 k probes, we annotated the number of
nucleotides at the intended site of hybridization that
mapped to repetitive DNA based on RepeatMasker
(http://www.repeatmasker.org; RepeatMasker, Institute
for Systems Biology, Seattle, WA, USA) annotation in
BLAT [30]. For 72,957 probes (15.0% of 450 k probes),
more than half of the nucleotides in the probe (>25 bps)
was targeted to repetitive DNA. We had annotated
19,731 of these repetitive probes as non-specific, which
reflects their in silico cross-hybridization. Interestingly,
for 24,847 specific probes (that is, mapped only to the
intended target), the entire probe (50 bps) was in repeti-
tive DNA. This group of specific repetitive probes might
be exploited to assess DNAm of repetitive elements; of
interest to studies investigating changes in DNAm in can-
cer or in association with environmental exposure [31,32].
Comparing Illumina and HIL annotation of probes
highlighted differences between CpG classification
systems
As previously mentioned, the 450 k array includes
probes designed to target UCSC CpG islands, as well as
shores, shelves and non-island regions, which we refer
to as the ‘sea’ [9] (Additional file 5A, see methods for
class definitions). Alternative ‘HIL’ CpG classes (that is,c probes
nded probe target: auto chrs Intended probe target: sex chrs
864 11,648
8 371
747
2 229
2 976
0 600
0 1,347
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island (IC) and non-island (LC)) provide a different criter-
ion for probe annotation based on CpG enrichment. We
expanded the 450 k annotation by categorizing probes
into four HIL classes: 1) HC probes, 2) IC probes, 3)
ICshore probes (regions of intermediate-density CpG is-
land that border HCs) and 4) LC probes (Additional file
5B, see methods for class definitions) [16,18].
The distribution of probes within each Illumina-
annotated CpG class was compared to the distribution of
probes within each HIL-annotated CpG class (Additional
file 6). The majority of probes were classified as anticipated,
with 77.6% of HIL-annotated HC probes annotated as
Illumina island probes, 65.0% of HIL-annotated ICshore
probes annotated as Illumina shore probes and 61.5% of
HIL-annotated LC probes annotated as Illumina sea probes
(Figure 2). The largest difference in annotation was that
close to half of HIL-annotated IC probes (51.0%) were
Illumina-annotated sea probes, while the remainder of IC
probes was distributed across Illumina-annotated islands
(17.2%), shores (19.9%) and shelves (11.9%).HC probes (n=153,859)
IC shore probes (n=33,955)
19.5%
(n=29,889)
0.3%
(n=492)
2.6%
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51
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Figure 2 Comparison of the genomic distribution of Illumina-annotat
Within HCs, ICshores and LCs, the majority of probes were categorized into
ICs and ICshores have the same CpG density, the distribution of probes ba
classes, suggesting a functional difference between ICs that border HCs an
island (HC), intermediate-density CpG island (IC) and non-island (LC); ICshoTo elucidate potential functional differences between
CpG classes, we examined the distribution of DNAm for
both Illumina and HIL-annotated CpG classes (for
blood, Additional file 7; buccal, Additional file 8 and
chorionic villi, Additional file 9). Within each classifica-
tion system, all distribution curves were significantly dif-
ferent from each other. On average, KS statistics were
larger for comparisons between HIL CpG classes than
for Illumina CpG classes (Additional files 7, 8, 9), indica-
tive of more distinct distributions of DNAm in HIL CpG
classes.
Using blood as example, ß values were separated into
three categories: hypomethylated (ß values of 0 to ≤0.2),
heterogeneously methylated (ß values of >0.2 to <0.8)
and hypermethylated (ß values of ≥0.8 to 1.0) (Figure 3
and Additional file 10) [7,33]. The majority of both HIL-
annotated HC probes (79.2%) and Illumina-annotated is-
land probes (72.3%) fell in the hypomethylated category
in blood, consistent with the characteristic pattern of
CpG island DNAm [33,34]. The distribution of DNAm
within Illumina-annotated shore probes, HIL-annotatedIC probes (n=118,727)
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Figure 3 Distinct patterns of DNAm within CpG classification
systems. Probes were grouped into three levels of DNAm based on
average ß values within a tissue: hypomethylated (ß values of 0 to
≤0.2, yellow), heterogeneously methylated (ß values of >0.2 to <0.8,
light blue) and hypermethylated (ß values of ≥0.8 to 1, dark blue).
The percentage of probes in Illumina and HIL-annotated CpG classes
was plotted for the three levels of DNAm in blood (n = 4). HIL CpG
classes were more characteristic in their DNAm profiles than
Illumina-annotated CpG classes. Numbers on top of bars indicate
number of probes/class. DNAm, DNA methylation; HIL, high-density
CpG island (HC), intermediate-density CpG island (IC) and non-island
(LC); ICshore, intermediate-density CpG island shore.
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ent (for example, in the hypomethylated category 34.0%,
13.6% and 46.1%, respectively), suggesting that these CpG
classes are distinctive. Interestingly, a higher proportion of
Illumina-annotated shelf probes than Illumina-annotated
sea probes were hypermethylated (72.6% vs 66.4% respect-
ively), perhaps attributable to the differing CpG enrich-
ment profile within shelves and seas (as demonstrated by
the contribution of HIL-annotated HC, IC and LC probes
to each of these classes, Additional file 6).
Previous studies have shown that tissue-specific differ-
ences in DNAm occur in CpG island shores [19]. We
were interested in assessing where tissue-specific differ-
ences in DNAm occur based on the Illumina versus HIL
CpG classes. Thus, we examined probes that were differ-
entially methylated between tissues (tDM) for enrich-
ment within each CpG class. The highest number of
tDM probes were identified between blood versus
chorionic villus samples (91,255, 21.3% of probes), in
comparison to chorionic villus versus buccal samples(75,021, 17.5% of probes) and blood versus buccal
samples (69,174, 16.2% of probes). tDM probes were sig-
nificantly depleted in Illumina-annotated islands and
HIL-annotated HCs, and significantly enriched in all
other CpG classes (Figure 4). Interestingly, the level of
enrichment within each CpG class varied by the tissues
compared (Figure 4 and Additional file 11).
A goal of the additional CpG classification of 450 k
probes was to identify biologically-relevant structures
that might underlie genome-wide changes in DNAm.
The HIL CpG classes demonstrated a more extreme
DNAm profile and larger percentage of tDM probes
which may be reflective of biological processes. Intri-
guingly, even though ICs and ICshores have the same
CpG density, distinct differences between these two
classes emerged in our analyses, suggesting that ICs that
border HCs are distinct from ICs on their own,
highlighting the utility of this additional classification.
DNAm was variable across nine gene feature groups
There is increasing evidence that DNAm of gene fea-
tures outside of CpG islands and promoters may be an
important marker of gene expression. For example, it
has been shown that DNAm of the first exon is corre-
lated with transcriptional repression [35]. Coverage of
regions outside of CpG islands and promoters was dra-
matically increased from the 27 k to 450 k array, how-
ever Illumina only categorized probes into six gene
feature groups: TSS1500 (within 1500 bps of a transcrip-
tion start site (TSS)), TSS200 (within 200 bps of a TSS),
5’UTR (5’ untranslated region), first exon, body and
3’UTR (3’ untranslated region). Given the number of
probes on the array, a more detailed gene structure clas-
sification might increase the potential to observe subtle
biologically-relevant trends in DNAm. Thus we expanded
on gene feature annotation by: 1) annotating the distance
of each probe to the closest TSS and 2) classifying probes
into nine groups based on three gene components (first
exons, exons and introns) and three gene regions (5’UTR,
body and 3’UTR). Probes were grouped into: 1) 5’UTR
first exons, 2) 5’UTR exons, 3) 5’UTR introns, 4) body
first exons, 5) body exons, 6) body introns, 7) 3’UTR first
exons, 8) 3’UTR exons and 9) 3’UTR introns using a)
transcript and b) RefGene name. Due to alternative TSS
and splicing, a given probe could be categorized into
several gene feature categories (Figure 5).
Due to the observed differences in DNAm across HIL
CpG classes detailed in the previous section, gene fea-
tures were further subclassified by HIL CpG class.
Given the known bias in the distribution of CpGs in the
genome [14], there was a predictable unequal distribu-
tion of the proportion of probes annotated to each HIL
CpG class across gene feature groups (Figure 6 and
Additional file 12). For example, HC probes were
% relative enrichment: blood vs. buccal
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Figure 4 Enrichment of differentially methylated probes in many CpG classes. Probes that were differentially methylated between blood
and buccal samples (n = 69,174), or between blood and chorionic villus samples (n = 91,255), were assessed for enrichment in (A) Illumina and
(B) HIL-annotated CpG classes. Enrichment was plotted as ‘percentage relative enrichment’, representing the enrichment of tDM probes relative
to the total percentage of probes within each CpG class. Negative percentage relative enrichment indicates that tDM probes were depleted in
the given probe-type category whereas positive percentage relative enrichment indicates that tDM probes were enriched in the given probe-
type category. All enrichment analyses were significant with the exception of ICshore probes in the comparison of blood versus chorionic villi.
HIL, high-density CpG island (HC), intermediate-density CpG island (IC) and non-island (LC); ICshore, intermediate-density CpG island shore; tDM,
differentially methylated between tissues.
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http://www.epigeneticsandchromatin.com/content/6/1/4significantly overrepresented in first exons found in the
5’UTR and gene body, while LC probes were signifi-
cantly underrepresented in both these groups. Within
each HIL CpG class, trends in DNAm across gene fea-
tures were consistent (Additional file 12). For example,
in blood, DNAm of intronic probes increased from
5’UTR to 3’UTR to gene body probes (Figure 7A), while
DNAm of 5’UTR probes increased from first exon to in-
tron to exon probes (Figure 7B).
We were also interested in assessing where tissue-
specific differences in DNAm occurred based on gene
features. Thus, we examined tDM probes for enrichment
within each gene feature group (again separated by CpG
class, Additional file 13). tDM probes in first exons were
significantly depleted in 5’UTRs located in HCs and
ICshores, but significantly enriched in 5’UTRs located in
LCs. HC exons were significantly enriched for tDM
probes in 5’UTR, body and 3’UTR across all tissue com-
parisons, perhaps due to biological significance or small
probe numbers in these categories. Although CpG clas-
ses were primarily associated with differences in DNAm,
gene structure is also an important factor to consider
when analyzing 450 k array results.Conclusion
With the advent of next-generation sequencing applied
to bisulfite converted samples, measurement of DNAm
will truly be possible on a genome-wide, sequence-
specific scale. However, difficulties currently lie in the
alignment of reduced complexity reads as well as
biologically-relevant interpretation of data [36]. Array-
based technologies, which target specific genomic regions
of interest, are of value for assessing physiologically-
relevant changes in studies of human health and disease.
Detailed and comprehensive annotation of locus-specific
arrays is paramount to successful analysis and interpret-
ation of data.
In this article, we presented an expanded annotation
of the 450 k array including both compromised probe
annotation and additional biologically-relevant annota-
tion. Our expanded annotation has been deposited as a
platform on the NCBI GEO (http://www.ncbi.nlm.nih.
gov/geo) under the accession [GSE:42409]. Based on our
findings, we suggest that all 450 k users analyze data
with the following factors in mind. Probe signals may be
biased by the presence of SNPs in the target CpG and/or
binding of probes to multiple genomic locations. SNPs
Ai ii iii
450k probes
2 5 8
B
1 3 9
C
3 6 8
D
4 8
E
7
Figure 5 Illustration of gene feature annotation. Based on the
overlap of three gene components (first exon vs exon vs intron)
with three gene regions (5’UTR vs body vs 3’UTR) probes were
annotated into the following nine gene feature groups: 1) 5’UTR first
exons, 2) 5’UTR exons, 3) 5’UTR introns, 4) body first exons, 5) body
exons, 6) body introns, 7) 3’UTR first exons, 8) 3’UTR exons and 9)
3’UTR introns (corresponding to numbers below transcripts). A given
probe could be annotated with more than one gene feature, as
illustrated by the multiple transcripts (A to E) of a fictional gene.
Probe i would be annotated as 5’UTR exon, 5’UTR first exon and
5’UTR intron; probe ii would be annotated as body exon, 5’UTR
intron, body intron, body first exon; and probe iii would be
annotated as 3’UTR exon, 3’UTR intron, 3’UTR exon, 3’UTR exon and
3’UTR first exon. White boxes represent untranslated exons, grey
boxes represent translated exons. 5’UTR, 5’ untranslated region;
3’UTR, 3’ untranslated region.
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Figure 6 Contribution of HIL CpG classes to probes in nine
gene feature groups. The percentage of probes within each HIL
CpG class was different for each gene feature group. Numbers on
top of bars indicate the number of probes/gene feature group; a
total of 213,315 probes were located within these nine gene feature
groups. HIL, high-density CpG island (HC), intermediate-density CpG
island (IC) and non-island (LC); ICshore, intermediate-density CpG
island shore.
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http://www.epigeneticsandchromatin.com/content/6/1/4at the target CpG may be especially problematic in stud-
ies with small sample size, as chance may result in dra-
matic differences in the frequency of polymorphisms
between groups. However, false positives may still result
in studies with larger sample sizes, if groups are not eth-
nically matched. Additionally, DNAm patterns within
CpG enrichment classes or gene features could over-
shadow findings between study groups if probes are not
separated and considered within these genomic features.
There are certainly other methods and filters that can
be applied to 450 k array analyses that were not touched
upon in this article. Notably, a recent study excluded
450 k probes that mapped to copy-number variations
(CNVs) because of the potential to bias measurement of
DNAm [37]. Furthermore these authors set a criterion
of ‘comethylation’ to identify differentially methylated
regions, that is, all probes within a 250 bp window had
to show the same trend in DNAm. As more studies
using the 450 k array are published, we will undoubtedly
see various combinations of applied filters and methodo-
logical practices for data analysis. In this era of extensive
data collection using such high-throughput assays, it is
vital that the type of biological sample as well as the re-
search question is carefully considered in relation to
downstream analytical choices as well as the technical
platform.Methods
Annotation
To complete the expanded annotation, we calculated
additional probe location information based on the
Illumina-provided MAPINFO GenomeStudio column
(location of the C in the target CpG): 1) the interval
of the target CpG (CpG), 2) the interval containing
the probe but excluding the target CpG (Probew/o CpG)
and 3) the interval of the entire probe (entire probe)
(Additional files 1 and 14). Probe type (type I vs type
II) and strand of design (F or R) were taken into con-
sideration when calculating genomic location. Ten type
I and ten type II probes were manually checked
against the annotated probe sequence. A UCSC track
was created containing the targeted Cs on the 450 k
array (Additional file 15). All of the annotation and
analysis of the expanded annotation was conducted on
485,512 probes, including both cg (CpG loci) and ch
(non-CpG loci) probes but excluding rs (SNP assay)
probes, unless otherwise specified.
SNP annotation
The dbSNP131 table was imported into Galaxy (http://
galaxyproject.org; Galaxy, Pennsylvania State Univer-
sity, PA, USA) from UCSC [38]. Only rs numbers for
SNPs that were an interval of 1 bp in length and of the
highest quality (weight = 1) were included in the anno-
tation. An interval file was uploaded into Galaxy using
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Figure 7 Variation of gene feature DNAm within a CpG class. The level of DNAm was plotted as an average ß value for each gene feature in
blood. Analyses were conducted within each HIL CpG class due to the large differences in DNAm that were observed between classes. Average ß
values varied across probes by (A) gene location, as exemplified by intronic probes and (B) gene components, as exemplified by 5’UTR probes.
5’UTR, 5’ untranslated region; DNAm, DNA methylation; HIL, high-density CpG island (HC), intermediate-density CpG island (IC) and non-island
(LC); ICshore, intermediate-density CpG island shore.
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probe spanning the C and G of the target CpG for cg
probes only. The probe file was intersected with the
dbSNP131 table to create a list of probes with docu-
mented SNPs in the C or G of the target CpG (target
CpG SNP). This file was collapsed in R (http://www.r-
project.org; R Foundation for Statistical Computing,
Vienna University of Economics and Business, Vienna,
Austria) to create a list of rs numbers for each probe,
since some target CpGs were documented with more
than one SNP. The rs numbers for SNPs in the target
CpG were included in the expanded annotation in the
‘target CpG SNP’ column (n = 20,270), while the num-
ber of SNPs/probes was annotated in the ‘n_target CpG
SNP’ column.
Non-specific probe annotation
To identify probes that potentially have multiple gen-
omic targets (non-specific probes), we followed the
method described by Chen et al. [10]. Special treatment
of type II probes was required as the Illumina annotation
has noted Cs in CpGs within the probe as an ‘R’ SNP.
For type II probes that contained Rs we considered two
probe sequence versions, one with all Rs replaced by Asand the other with all Rs replaced by Gs. Using these con-
ditions, we matched each of the 450 k probes with the
Illumina-annotated genomic location (intended target).
Briefly, we used BLAT [30] to align probe sequences
to four versions of the hg19 draft sequence genome: 1) a
fully unmethylated ‘bisulfite treated’ genome, with all Cs
converted to Ts; 2) a fully methylated ‘bisulfite treated’
genome, with only non-CpG Cs converted to Ts; 3) and
4) were the above treatments on the reverse comple-
ment sequence. BLAT was run using the following pa-
rameters: stepSize = 5, wordsize = 11 and repMatch =
1,000,000; lowering the word length led to only fraction-
ally more hits. The selection criterion used was as
previously outlined: for a probe to be considered non-
specific, there had to be 90% identity over the aligned
region, at least 40 of 50 matching bps, no gaps, and the
50th nucleotide had to align, as the probe hybridizes to
the target CpG at this position [10]. The number of
non-specific probes hits were annotated in the ex-
panded annotation ‘AlleleA_Hits, AlleleB_Hits’ columns,
while the site of cross-hybridization was annotated in
the columns ‘XY_Hits’ (if at least one hit was on a sex
chromosome) and ‘Autosomal_Hits’ (if at least one hit was
on an autosomal chromosome). Repetitive sequences from
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nomes. Thus we identified the amount of repetitive DNA
within the Illumina-intended alignment of each probe in
the expanded annotation column ‘n_bp_repetitive’.
CpG enrichment annotation
Illumina categorized probes in CpG islands (GenomeStudio
column ‘Relation_to_UCSC_CpG_Island’) based on the
UCSC Genome Browser criteria of CG content >50%, Obs/
Exp CpG ratio >0.60 and length >200 bps. Shores and
shelves were identified based on their relationship to a CpG
island; shores as the 2 kbs up- and down-stream of CpG
islands and shelves as the 2 kbs outside of shores. The
remaining probes were located in non-island regions, which
we refer to as the ‘sea’ [9] (Additional file 5A).
We annotated probes into four HIL CpG classes based
on alternative CpG enrichment criteria: high-density
CpG island probes (HC, n = 153,859), intermediate-
density CpG island probes (IC, n = 118,727), ICshore
probes (probes in ICs that border HCs, n = 33,955) and
non-island probes (LC, n = 178,971) (Additional file 5B).
This annotation has been added in the ‘HIL_CpG_class’
column of the expanded annotation. To locate probes
within each of the four CpG classes, we first annotated
these CpG enrichment classes throughout the genome.
The hg19 genomic sequence was downloaded from
UCSC in overlapping segments and read by CpGIE, a
Java software program [39]. CpGIE searches input se-
quences in sliding windows based on user-set criteria.
HCs were defined as regions with CG content >55%,
Obs/Exp CpG ratio >0.75 and length >500 bps, while
ICs were defined as regions with CG content >50%,
Obs/Exp CpG ratio >0.48 and length >200 bps [16,18].
CpGIE HC and IC output was merged into a single file
for each chromosome, duplicate islands were removed
and CpG islands were identified as follows: ICs, isolated
regions of the genome with IC density; ICshores, regions
of the genome with IC density that were next to regions
with HC density; HCs, any region of the genome with
HC density; and LCs, regions that were not of IC or HC
density. Islands were given unique names in the annota-
tion, for example, chr8_IC:49890018–49891221 (chr#_CpG
class: genomic start–genomic end). The hg19 HC and IC
islands have been complied into a UCSC track available in
Additional file 16. The hg19 HIL annotation was
intersected with the genomic location (hg19) of 450 k tar-
gets in Galaxy to assign probes into the four CpG classes.
An annotation of probes into HIL CpG islands using the
detailed nomenclature can be found in the expanded anno-
tation column ‘HIL_CpG_Island_Name’.
Gene feature and TSS annotation
Using the NCBI Reference Sequence (RefSeq) gene an-
notation, we annotated probes into nine groups basedon three gene components (first exons, exons and
introns) and three gene regions (5’UTR, body and
3’UTR). Probes were grouped into: 1) 5’UTR first exons,
2) 5’UTR exons, 3) 5’UTR introns, 4) body first exons,
5) body exons, 6) body introns, 7) 3’UTR first exons, 8)
3’UTR exons and 9) 3’UTR introns (Figure 5). Briefly,
the hg19 RefSeq table was downloaded from UCSC [38].
Exon and intron information was extracted and parsed
into genomic interval data with the most upstream exon
denoted as the first exon. Next, 5’UTR, gene body and
3’UTR location was parsed into genomic interval data
utilizing the transcription start/stop and coding start/
stop information from RefSeq. Intersection was performed
between each of 5’UTR, gene body and 3’UTR with first
exon, exon and intron intervals to generate the nine gene
features. The gene feature intervals were then intersected
with the hg19 genomic location of 450 k targets in R to as-
sign probes into the nine gene features. This annotation
was completed using both RefSeq gene names and tran-
script names. Gene feature annotation was conducted
using the GenomicRanges package in R [40].
The hg19 UCSC knownGene table [38] was downloaded
to Galaxy and the closest TSS for each probe was anno-
tated, regardless of whether the probe was located within
the same gene. For each probe, the distance to the closest
TSS, gene name and transcript name was noted in the ex-
panded annotation columns ‘Closest_TSS’, ‘Distance_
closest_TSS’, ‘Closest_TSS_gene_name’ and ‘Closest_TSS_
Transcript’.
Sample collection
Two male and two female chorionic villus samples were
collected through the BC Women’s Hospital & Health
Centre, Vancouver, BC, Canada, as controls for a study
of chromosomal abnormalities in the placenta. DNA was
extracted from a small piece of chorionic villi as previ-
ously described [41]. For each placental sample (n = 4),
DNA from two independent chorionic villi was com-
bined in equal amounts prior to bisulfite conversion to
ensure a representative sample of the placenta. DNA
was extracted by standard salt method. Two male and
two female blood samples were collected as adult con-
trols for ongoing studies of respiratory disease and epi-
genetics (n = 4). Peripheral blood mononuclear cell
(PBMC) DNA was extracted according to standard pro-
cedures. Buccal epithelial samples were collected from
two males and two females for a study on maternal care
effects on childhood DNAm (n = 4). Buccal samples
were collected using Isohelix DNA Buccal Swabs (Cell
Projects Ltd, Harrietsham, Kent, UK), and stabilization
reagents and DNA were extracted using Isohelix DNA
Isolation Kits (Cell Projects Ltd) as per the manufac-
turer’s protocols.
Price et al. Epigenetics & Chromatin 2013, 6:4 Page 12 of 15
http://www.epigeneticsandchromatin.com/content/6/1/4Illumina 450 k array
Two ug of genomic DNA was purified using the DNeasy
Blood & Tissue Kit (Qiagen, Valencia, CA, USA) follow-
ing the manufacturer’s protocol. Purified DNA quality
and concentration were assessed with a NanoDrop ND-
1000 (Thermo Scientific, Waltham, MA, USA) prior to
bisulfite conversion. One ug of purified genomic DNA
was bisulfite converted using the EZ DNA Methylation
Kit (Zymo Research, Orange, CA, USA) following the
manufacturer’s protocol. Bisulfite DNA quality and con-
centration were assessed using the NanoDrop and, if re-
quired, samples were concentrated to approximately 50
ng/ul using a SpeedVac (Thermo Electron Corporation,
Waltham, MA, USA). Following the Illumina 450 k array
protocol, 4 ul of bisulfite converted sample was whole-
genome amplified, enzymatically digested, hybridized to
the array and then single nucleotide extension was
performed [9].
Two assay types are used by the 450 k array to meas-
ure DNAm: Infinium I (type I probes) and Infinium II
(type II probes), bound to beads scattered throughout
the array. When a probe successfully binds to DNA, a
single fluorescently labeled nucleotide extends off the
probe and this signal is read by an Illumina scanner. The
Infinium I assay uses two bead types specific to the CpG
of interest: an unmethylated (u) and a methylated (m)
bead, each with a different probe design (ProbeA (u) and
ProbeB (m)). Both type I probes for a given CpG fluor-
esce in the same color channel (either red (Cy5) or green
(Cy3)). The Infinium II assay uses only one bead type for
each CpG of interest, an m + u bead. One probe is
designed for each type II target site and the color of
fluorescence is based on which nucleotide is incorpo-
rated in the single base extension step. The incorpor-
ation of an A or T signals an unmethylated site in red
(u) and the incorporation of a C or a G signals a methyl-
ated site in green (m) [8].
Chips were scanned using an Illumina HiScan on a
two-color channel to detect Cy3 labeled probes on the
green channel and Cy5 labeled probe on the red chan-
nel. Illumina GenomeStudio Software 2011.1 was used
to read the array output and conduct background
normalization. The signalA, signalB and probe intensity
were exported for autosomal probes and read into R. M
values were generated using the Bioconductor (http://
www.bioconductor.org; Fred Hutchinson Cancer Re-
search Center, Seattle, WA, USA) methylumi package,
M = log2(intensity m + 1/intensity u + 1) since this value
has been shown to be valid for statistical analyses [42].
Following correction for chip to chip color bias using
the Bioconductor lumi package [43] and probe type cor-
rection using subset-quantile within array normalization
(SWAN) [44], M values were converted to ß values using
the equation ß = (2M/(2M + 1)). The ß value is a numberranging from 0 to 1 that is directly proportional to per-
centage DNAm; thus to ease interpretation, we have
reported results as ß values. The microarray data used in
this article was submitted to the NCBI GEO under ac-
cession number [GSE:42409]. Probes with a detection p
value >0.01 in any sample, probes with no ß value in any
sample, all rs and ch probes, all sex chromosome and
non-specific probes were removed prior to analyses. The
level of DNAm for 428,216 probes in our sample dataset
was intersected with the expanded annotation for further
analyses.
Processing of aging dataset
Series matrix files were downloaded for [GSE:40279]
containing ß values for 473,039 probes per sample [24].
We worked with the subset of samples that roughly
matched the age of the samples used in our study (n =
261, aged 19 to 61 years). Probes with no ß value in any
sample, all sex chromosome probes, all rs and all ch
probes were removed from the dataset. For SNP ana-
lyses, non-specific probes were also removed, however
these were retained in the analysis of autosomal sex-
specific probes. For the discovery of autosomal probes
with sex differences in DNAm, ß values were read into
R, converted into M values using the Bioconductor pack-
age lumi [43] and then significance analysis of microarrays
(SAM) was conducted using the Bioconductor package
siggenes [45]. At FDR <1%, 10,139 autosomal probes were
identified as significantly different between male and fe-
male samples. Next, this list was crossed with a list of Δß
values for each probe calculated by taking the absolute
value of the difference between average ß of males and
average ß of females.
Pyrosequencing
Probe cg06961873 was selected for genotype validation
of SNP rs61775206 in each sample. Primers were
designed using PSQ Assay Design software version 1.0.6
(Biotage AB, Uppsala, Sweden). Primer sequences and
probe information are available in Additional file 17.
Using the following conditions, 0.5 ul of genomic DNA
was PCR-amplified: 95°C for 5 minutes, (95°C for 20 sec-
onds, 55°C for 20 seconds, 75°C for 20 seconds) × 50,
72°C for 5 minutes. Genotyping was performed using a
PyroMark MD system (Biotage AB) and analyzed with
PSQ 96MA SNP software (Biotage AB).
Statistical analyses
A KS test was used to assess the difference in distribu-
tion of SD in ß values for probes that contained SNPs.
The KS statistic represents the maximum absolute
difference between the cumulative distributions of two
functions. Probes with small within-tissue SD in ß
(<0.10) were removed from all probe groups to increase
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were removed from the SNP <10 bp group. The number
of probes included in the SD in ß distribution curves for
blood samples was 5,450 for all probes, 809 for SNP >10
bp, 402 for SNP <10 bp and 2,190 for target CpG SNP,
and for the aging dataset was 6,267 for all probes, 1,022
for SNP >10 bp, 362 for SNP <10 bp and 2,753 for target
CpG SNP. KS tests were also used to assess the differ-
ence in distribution of DNAm between Illumina CpG
classes and between HIL CpG classes. Fisher’s exact test
was used to compare the distribution of the number of
probes within the three levels of DNAm for both Illumina
and HIL-annotated CpG classes: hypomethylated (ß
values of 0 to ≤0.2), heterogeneously methylated (ß values
of >0.2 to <0.8) and hypermethylated (ß values of ≥0.8 to
1.0). Enrichment analyses of tDM probes were performed
in Python (Python Software Foundation). To select tDM
probes, DNAm was first averaged for each probe within a
tissue. A z-score was calculated for each probe compari-
son between tissues. A p value cutoff of 0.05 was selected
with a Bonferroni correction to account for repeated com-
parisons [19]. KS and Fisher’s exact tests were performed
in R. Statistical significance was considered as tests with p
values <1.0 × 10-7. All figures were created in R and
Adobe Illustrator CS6.Additional files
Additional file 1: Relative location of probes to target CpG. To
complete our analysis, it was necessary to locate 450 k probes within the
genome. Illumina annotated the hg19 location of each target C (called
mapinfo) and the strand on which the probe was designed; R probes
bind to the negative strand, whereas F probes bind to the positive
strand. With this information we annotated the start and end coordinates
for all probes on the array. Refer to Additional file 14 for the start and
end location for each probe type. Type I versus type II probes and F
versus R probes align differently with target CpGs. Single nucleotide
extension of a probe occurs by one of four fluorescently labeled
nucleotides, A and T are labeled in red, while C and G are labeled in
green. The color of single nucleotide extension of type I probes is not
dependant on whether the target site is methylated or unmethylated;
however, for type II probes, incorporation of an A or T signals an
unmethylated site in red and the incorporation of a C or a G signals a
methylated site in green.
Additional file 2: Frequency of target SNP CpG/probe.
Additional file 3: Distribution of DNAm at three highly variable
probes. The level of DNAm was plotted for three highly variable probes
(SD in ß ≥0.25) annotated with a target CpG SNP, across the 261
individuals in the aging dataset. cg06961873 corresponds to the CpG site
genotyped in Figure 1D. A trimodal pattern of DNAm was observed at
these three exemplary sites, indicating that DNAm measured at these
sites may reflect sample genotype.
Additional file 4: List of autosomal probes with sex differences in
DNAm.
Additional file 5: Illustration of Illumina and HIL CpG classes. (A)
Diagram of Illumina-annotated probes, based on their relative location to
a CpG island: within the island, shore or shelf. We used the term ‘sea
probes’ to refer to probes that were not annotated into one of the
Illumina CpG classes. Islands were defined based on UCSC criteria: CG
content >50%, Obs/Exp, CpG ratio >0.60 and length >200 bps. Shoreswere defined as the 2 kb up- and down-stream of a CpG island and
shelves as the 2 kb outside of a shore. (B) The HIL definition of CpG
islands was used to annotate probes into three CpG classes: HC probes
(map to a high-density CpG island or HC), IC probes (map to an isolated
intermediate-density CpG island or IC) and ICshore probes (map to a
region with IC density that borders an HC). The remainder of probes did
not map to a CpG island and were thus considered non-island or LC
probes. HCs were defined as CG content >55%, Obs/Exp CpG ratio >0.75
and length >500 bps, while ICs were defined as CG content >50%, Obs/
Exp CpG ratio >0.48 and length >200 bps.
Additional file 6: Distribution of probes within Illumina-annotated
and HIL-annotated CpG classes.
Additional file 7: Distinct patterns of DNAm across Illumina-
annotated and HIL-annotated CpG classes in blood. Density curves
were plotted using average ß values for probes within each Illumina-
annotated and HIL-annotated CpG class in blood (n = 4). The number of
probes contributing to each curve was: island = 136,712, shore = 100,083,
shelf = 39,833, sea = 151,588, HC = 139,826, ICshore = 100,164, IC =
30,467 and LC = 157,759. For Illumina-annotated CpG classes, KS statistics
in comparison to the distribution of DNAm of sea probes was 0.67 for
island probes, 0.34 for shore probes and 0.06 for shelf probes. For HIL-
annotated CpG classes, KS statistics in comparison to the distribution of
DNAm of LC probes was 0.77 for HC probes, 0.53 for ICshore probes and
0.08 for IC probes.
Additional file 8: Distinct patterns of DNAm across Illumina-
annotated and HIL-annotated CpG classes in buccal samples.
Density curves were plotted using average ß values for probes within
each Illumina-annotated and HIL-annotated CpG class in buccal samples
(n = 4). The number of probes contributing to each curve was: island =
136,712, shore = 100,083, shelf = 39,833, sea = 151,588, HC = 139,826,
ICshore = 100,164, IC = 30,467 and LC = 157,759. For Illumina-annotated
CpG classes, KS statistics in comparison to the distribution of DNAm of
sea probes was 0.66 for island probes, 0.32 for shore probes and 0.06 for
shelf probes. For HIL-annotated CpG classes, KS statistics in comparison
to the distribution of DNAm of LC probes was 0.76 for HC probes, 0.49
for ICshore probes and 0.07 for IC probes.
Additional file 9: Distinct patterns of DNAm across Illumina-
annotated and HIL-annotated CpG classes in chorionic villi. Density
curves were plotted using average ß values for probes within each
Illumina-annotated and HIL-annotated CpG class in chorionic villi (n = 4).
The number of probes contributing to each curve was: island = 136,712,
shore = 100,083, shelf = 39,833, sea = 151,588, HC = 139,826, ICshore =
100,164, IC = 30,467 and LC = 157,759. For Illumina-annotated CpG
classes, KS statistics in comparison to the distribution of DNAm of sea
probes was 0.61 for island probes, 0.28 for shore probes and 0.08 for
shelf probes. For HIL-annotated CpG classes, KS statistics in comparison
to the distribution of DNAm of LC probes was 0.72 for HC probes, 0.45
for ICshore probes and 0.10 for IC probes.
Additional file 10: Distribution of ß values within Illumina-
annotated and HIL-annotated CpG classes for blood.
Additional file 11: Enrichment of differentially methylated probes
in Illumina-annotated and HIL-annotated CpG classes.
Additional file 12: Average DNAm and SD of nine gene features.
Additional file 13: Enrichment of tDM probes within gene features.
Additional file 14: Calculation of intended genomic location of
450k probes.
Additional file 15: UCSC track of 450 k target Cs.
Additional file 16: UCSC track of HC/IC CpG islands.
Additional file 17: Primers for genotyping validation of a target
CpG SNP.Abbreviations
27 k: Infinium HumanMethylation27k BeadChip; 3’UTR: 3’ untranslated region;
450 k: Infinium HumanMethylation450 BeadChip; 5’UTR: 5’ untranslated
region; auto: autosomal; bp: base pair; chrs: chromosomes; CNV: copy-
number variation; dbSNP: database of single nucleotide polymorphisms;
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wide association studies; HC: high-density CpG island; HIL: high-density CpG
island (HC), intermediate-density CpG island (IC) and non-island (LC) or low-
density regions; IC: intermediate-density CpG island; ICshore: intermediate-
density CpG island shore; KS: Kolmogorov-Smirnov; LC: non-island;
mSNP: methylation-associated SNP; NCBI: National Center for Biotechnology
Information; Obs/Exp: Observed/Expected; PBMC: peripheral blood
mononuclear cell; PCR: polymerase chain reaction; RefSeq: Reference
Sequence; SAM: significance analysis of microarrays; SNP: single nucleotide
polymorphism; SWAN: subset-quantile within array normalization;
tDM: differentially methylated between tissues; TSS: transcription start site;
UCSC: University of California, Santa Cruz.
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